Tabata Y, Hong L, Miyamoto S, Miyao M, Hashimoto N, Ikada Y
Institute for Frontier Medical Sciences, Kyoto University, Japan.
J Biomater Sci Polym Ed. 2000;11(8):891-901. doi: 10.1163/156856200744084.
The objective of the present study is to investigate the addition effect of transforming growth factor (TGF)-beta1 on the bone formation at a rabbit skull defect induced by autologous bone marrow (BM). Following application of gelatin microspheres containing TGF-beta1, with or without BM cells to skull bone defects, bone formation at the defect was assessed by soft X-ray, dual energy X-ray absorptometry (DEXA), and histological examinations. After implantation for 6 weeks, gelatin microspheres containing 0.05 microg of TGF-beta1 plus 10(6) of BM cells induced bone formation at the 6 mm diameter bone defect. The defect was histologically closed by newly formed bone tissue, whilst both gelatin microspheres containing 0.05 microg of TGF-beta1, and 10(6) and 10(7) of BM cells were ineffective. A DEXA experiment revealed that combination of gelatin microspheres containing TGF-beta1 with BM cells enhanced the bone mineral density at the skull defect to a significantly greater extent than other agents. These findings indicate that a combination of gelatin microspheres containing TGF-beta1 enabled BM cells to enhance the osteoinductive ability, resulting in bone formation even at the cell number at which BM cells alone were ineffective.
本研究的目的是探讨转化生长因子(TGF)-β1对自体骨髓(BM)诱导的兔颅骨缺损处骨形成的加成作用。在将含或不含BM细胞的含TGF-β1明胶微球应用于颅骨缺损后,通过软X线、双能X线吸收法(DEXA)和组织学检查评估缺损处的骨形成情况。植入6周后,含0.05μg TGF-β1加10⁶个BM细胞的明胶微球在直径6mm的骨缺损处诱导了骨形成。组织学检查显示,缺损被新形成的骨组织封闭,而含0.05μg TGF-β1的明胶微球以及10⁶和10⁷个BM细胞单独应用时均无效。DEXA实验显示,含TGF-β1的明胶微球与BM细胞联合应用比其他制剂能更显著地提高颅骨缺损处的骨矿物质密度。这些发现表明,含TGF-β1的明胶微球组合能使BM细胞增强骨诱导能力,即使在单独BM细胞数量无效的情况下也能导致骨形成。